Countdown to Ethereum Pectra Upgrade Activation: Learn more
$2.62T
Total marketcap
$245.8B
Total volume
BTC 60.52%     ETH 7.27%
Dominance

Therapeutic TSOI Stock

0.0003 USD {{ price }} 50.000008% {{change_pct}}%
Market Cap
1.54M USD
LOW - HIGH [24H]
0.0002 - 0.0002 USD
VOLUME [24H]
20K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Therapeutic Price Chart

Therapeutic TSOI Financial and Trading Overview

Therapeutic stock price 0.0003 USD
Previous Close 0.0003 USD
Open 0.0002 USD
Bid 0.0002 USD x 0
Ask 0.0003 USD x 0
Day's Range 0.0002 - 0.0002 USD
52 Week Range 0.0001 - 0.0011 USD
Volume 20K USD
Avg. Volume 39.95M USD
Market Cap 1.02M USD
Beta (5Y Monthly) 1.238
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

TSOI Valuation Measures

Enterprise Value 2.9M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 12.0083685
Price/Book (mrq) N/A
Enterprise Value/Revenue 34.001
Enterprise Value/EBITDA -0.884

Trading Information

Therapeutic Stock Price History

Beta (5Y Monthly) 1.238
52-Week Change -62.50%
S&P500 52-Week Change -2.46%
52 Week High 0.0011 USD
52 Week Low 0.0001 USD
50-Day Moving Average 0.000268 USD
200-Day Moving Average 0.00054205 USD

TSOI Share Statistics

Avg. Volume (3 month) 39.95M USD
Avg. Daily Volume (10-Days) 5.76M USD
Shares Outstanding 5.12B
Float 4.02B
Short Ratio N/A
% Held by Insiders 21.52%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2023
Most Recent Quarter (mrq) September 30, 2024
Next Fiscal Year End December 31, 2024

Profitability

Profit Margin 0%
Operating Margin (ttm) -9963.49%
Gross Margin 65.80%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -63.49%
Return on Equity (ttm) -250.40%

Income Statement

Revenue (ttm) 85.32K USD
Revenue Per Share (ttm) 0 USD
Quarterly Revenue Growth (yoy) -23.59%
Gross Profit (ttm) 56.14K USD
EBITDA -3281793 USD
Net Income Avi to Common (ttm) -2410213 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 9.23K USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 929.63K USD
Total Debt/Equity (mrq) 55.28 USD
Current Ratio (mrq) 0.271
Book Value Per Share (mrq) 0

Cash Flow Statement

Operating Cash Flow (ttm) -484108 USD
Levered Free Cash Flow (ttm) 317.21K USD

Profile of Therapeutic

Country United States
State ID
City Elk City
Address 701 Wild Rose Lane
ZIP 83525
Phone 760 295 7208
Website https://www.therapeuticsolutionsint.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 3

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. It also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPSA, a blend of NanoStilbene and broccoli sprout extracts; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. In addition, the company develops therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology; and portfolio of immunotherapies that provides dendritic cell vaccines for cancers to Parkinson's disease developed on StemVacs platform. Therapeutic Solutions International, Inc. was founded in 2007 and is headquartered in Elk City, Idaho.

Q&A For Therapeutic Stock

What is a current TSOI stock price?

Therapeutic TSOI stock price today per share is 0.0003 USD.

How to purchase Therapeutic stock?

You can buy TSOI shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Therapeutic?

The stock symbol or ticker of Therapeutic is TSOI.

Which industry does the Therapeutic company belong to?

The Therapeutic industry is Biotechnology.

How many shares does Therapeutic have in circulation?

The max supply of Therapeutic shares is 5.12B.

What is Therapeutic Price to Earnings Ratio (PE Ratio)?

Therapeutic PE Ratio is now.

What was Therapeutic earnings per share over the trailing 12 months (TTM)?

Therapeutic EPS is 0 USD over the trailing 12 months.

Which sector does the Therapeutic company belong to?

The Therapeutic sector is Healthcare.